Testing effectiveness (Phase 2)Study completedNCT00028002
What this trial is testing
Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor
Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 63